title: Structural aspects of autophagy.
abstract: As a first step towards isolation of autophagic sequestering membranes (phagophores), we have purified autophagosomes from rat hepatocytes. Lysosomes were selectively destroyed by osmotic rupture, achieved by incubation of hepatocyte homogenates with the cathepsin C substrate glycyl-phenylalanyl-naphthylamide (GPN). Mitochondria and peroxisomes were removed by Nycodenz gradient centrifugation, and cytosol, microsomes and other organelles by rate sedimentation through metrizamide cushions. The purified autophagosomes were bordered by dual or multiple concentric membranes, suggesting that autophagic sequestration might be performed either by single autophagic cisternae or by cisternal stacks. Okadaic acid, a protein phosphatase inhibitor, disrupted the hepatocytic cytokeratin network and inhibited autophagy completely in intact hepatocytes, perhaps suggesting that autophagy might be dependent on intact intermediate filaments. Vinblastine and cytochalasin D, which specifically disrupted microtubules and microfilaments, respectively, had relatively little (25-30%) inhibitory effect on autophagic sequestration. In a cryo-ultrastructural study, the various autophagic-lysosomal vacuoles were immunogold-labelled, using the cytosolic enzyme superoxide dismutase as an autophagic marker, Lgp120 as a lysosomal membrane marker, and bovine serum albumin as an endocytic marker. Vinblastine (50 microM) was found to inhibit both autophagic and endocytic flux into the lysosomes, with a consequent reduction in lysosomal size. Asparagine (20 mM) caused swelling of the lysosomes, probably as a result of the ammonia formation that could be observed at this high asparagine concentration. Autophagosomes and amphisomes (autophagic-endocytic, prelysosomal vacuoles) accumulated in asparagine-treated cells, reflecting an inhibition of autophagic flux that might be a consequence of lysosomal dysfunction.
authors.affiliation: Department of Tissue Culture, Institute for Cancer Research, Norwegian Radium Hospital, Montebello, Oslo, Norway.
authors.forename: P O
authors.initials: PO
authors.lastname: Seglen
authors.forename: T O
authors.initials: TO
authors.lastname: Berg
authors.forename: H
authors.initials: H
authors.lastname: Blankson
authors.forename: M
authors.initials: M
authors.lastname: Fengsrud
authors.forename: I
authors.initials: I
authors.lastname: Holen
authors.forename: P E
authors.initials: PE
authors.lastname: Strømhaug
mesh_terms: D000818:Animals; D001216:Asparagine / Q000494:pharmacology; D001343:Autophagy / Q000187:drug effects / Q000502:physiology*; D003593:Cytoplasm / Q000187:drug effects / Q000378:metabolism*; D003599:Cytoskeleton / Q000187:drug effects / Q000502:physiology; D008247:Lysosomes / Q000187:drug effects / Q000378:metabolism*; D010588:Phagosomes / Q000187:drug effects / Q000378:metabolism*; D014617:Vacuoles / Q000187:drug effects / Q000378:metabolism*; D014747:Vinblastine / Q000494:pharmacology
chemical_list: D014747:Vinblastine; D001216:Asparagine